Last reviewed · How we verify
Diclofenac and Paracetamol
At a glance
| Generic name | Diclofenac and Paracetamol |
|---|---|
| Also known as | Placebo |
| Sponsor | Hamad Medical Corporation |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pain Control After Open Radical Nephrectomy: Thoracic Paravertebral Block Versus External Oblique Intercostal Block (NA)
- Helping Osteoarthritis Patients to Walk With NSAID (PHASE4)
- Clinical Application of Dynamic Multimodal Analgesia Regimen After Perianal Abscess Surgery (NA)
- Effect of Single Dose Intravenous Magnesium Sulfate on Postoperative Analgesic Consumption in Patients Undergoing Laparoscopic Cholecystectomy (PHASE4)
- Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery (NA)
- Efficacy of Genicular Block on Total Knee Arthroplasty Surgery (NA)
- Continue ESPB & Continue ESPB Combined With SAPB for Thoracotomy (NA)
- Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diclofenac and Paracetamol CI brief — competitive landscape report
- Diclofenac and Paracetamol updates RSS · CI watch RSS
- Hamad Medical Corporation portfolio CI